BG Medicine (Waltham, MA) focused on the discovery, development and commercialization of molecular biomarkers and diagnostics, closed a $40M Series D financing. Participants include Legg Mason Capital Management, GE Asset Management, SmallCap World Fund, Flagship Ventures, Gilde Healthcare Partners, Humana, and Stelios Papadopoulos.